News
-
-
COMMUNIQUÉ DE PRESSE
RESULTS AT 30 JUNE 2026 IN LINE WITH FORECASTS
Hexaom reports strong financial performance in H1 2026 with a 59.8% increase in current operating income to €19.5 million, net cash of €71.0 million, and resilient sales. Outlook for 2026 includes revenue growth and improved profitability -
-
-
COMMUNIQUÉ DE PRESSE
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
Napo Pharmaceuticals announced the acceptance of an abstract on crofelemer powder study for SBS-IF at ACG 2026. Napo focuses on global crofelemer development for rare IF diseases -
-
-
COMMUNIQUÉ DE PRESSE
LionVolt opens Flight One early access to UAV OEMs
LionVolt launches Flight One early access program for high-energy cell technology for UAV OEMs, offering enhanced endurance, range, and payload capacity. Lithium-metal cells with 400 Wh/kg energy and 5C discharge rates. Supply chain based in Europe -
-
![Logo de [UNKNOWN]](https://logos.symex.be/img/.jpg)
